KISS1R and endometriosis: The examination of the kisspeptin receptor revealed statistically significant differences in the comparison of the control group in stage I (p = 0.003), stage III (p = 0.02), and stage IV (p = 0.03) of extragenital endometriosis (Figure 2b).